Lv1
40 积分 2026-04-02 加入
Hypoxia-Inducible Factor-Prolyl Hydroxylase Domain Inhibitors to Treat Anemia in Chronic Kidney Disease
4天前
已完结
Difference in Therapeutic Effects between Roxadustat and Daprodustat, HIF-Ph Inhibitors, Depending on the Blood Type in Hemodialysis (HD) Patients
1个月前
已关闭
Hypoxia signaling in renal pericytes—is it safe to activate?
1个月前
已关闭
INDOXYL SULFATE IS A KEY PLAYER IN THE CARDIORENAL ANEMIA SYNDROME AND PREDICTS THE CLINICAL OUTCOME AFTER ACUTE DECOMPENSATED HEART FAILURE
1个月前
已完结
A new approach to treating renal anaemia
1个月前
已完结
Targeting epigenetics in renal anaemia
1个月前
已完结
iPSC-derived EPO-producing cells rescue anaemia
1个月前
已完结
皖公网安备34019202002308
